4.7 Review

Bioactive DNA from extracellular vesicles and particles

期刊

CELL DEATH & DISEASE
卷 11, 期 7, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41419-020-02803-4

关键词

-

资金

  1. Gattuso-Slaight Personalized Cancer Medicine Fund from the Princess Margaret Cancer Foundation
  2. Princess Margaret Cancer Centre Discovery Program
  3. Wharton Family
  4. Joe's Team
  5. Gordon Tozer and the Reed Fund
  6. Conquer Cancer Foundation of ASCO
  7. Cancer Research Society
  8. Canadian Cancer Society Research Institute
  9. Canadian Institutes of Health Research

向作者/读者索取更多资源

Extracellular vesicles (EVs) and particles (EPs) have recently emerged as active carriers of molecular biomarkers and mediators of intercellular communication. While most investigations have focused exclusively on the protein, lipid and RNA constituents of these extracellular entities, EV/EP DNA remains poorly understood, despite DNA being found in association with virtually all EV/EP populations. The functional potential of EV/EP DNA has been proposed in a number of pathological states, including malignancies and autoimmune diseases. Moreover, the effectiveness of cell-free DNA as the biomarker of choice in emerging liquid biopsy applications highlights the role that EV/EP DNA may play as a novel disease biomarker. In this review, we provide a comprehensive overview of EV/EP DNA studies conducted to date, with a particular focus on the roles of EV/EP DNA as a functional mediator and molecular biomarker in various pathologic states. We also review what is currently known about the origins, structure, localisation and distribution of EV/EP DNA, highlighting current controversies as well as opportunities for future investigation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, Research & Experimental

Cell-free DNA topology depends on its subcellular and cellular origins in cancer

Ethan Z. Malkin, Steven De Michino, Meghan Lambie, Rita Gill, Zhen Zhao, Ariana Rostami, Andrea Arruda, Mark D. Minden, Scott V. Bratman

Summary: Cancer cells release cfDNA, which is predominantly associated with nucleosomal particles and not EVs. Additionally, a subset of mitochondrial cfDNA is membrane protected and derived from non-tumor cells. These findings have important implications for understanding the topology of cfDNA in cancer.

JCI INSIGHT (2022)

暂无数据